Is sporadic alzheimer's disease associated with diphtheria toxin?

Journal of Alzheimer's Disease

Volumn 34, Issue 3, 2013, Pages 595-600

  Merril, Carl R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Alzheimer's disease; booster vaccine; diphtheria toxin; DPT vaccine; EF2; elongation factor 2; immune system; vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TOXIN;

ALZHEIMER DISEASE; ARTICLE; CHONDROPROTECTION; CORYNEBACTERIUM DIPHTHERIAE; DISEASE ASSOCIATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SPORADIC ALZHEIMER DISEASE; VACCINATION;

EID: 84876376190     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121948     Document Type: Article

References (35)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3, 186-191. (Pubitemid 46825511)
2. Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB (2007) Prevalence of dementia in the United States: The aging, demographics, and memory study. Neuroepidemiology 29, 125-132. (Pubitemid 350191430)
3. Qiu C, Kivipelto M, von Strauss E (2009) Epidemiology of Alzheimer's disease: Occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11, 111-128.
4. Wozniak MA, Itzhaki RF (2010) Antiviral agents in Alzheimer's disease: Hope for the future? Ther Adv Neurol Disord 3, 141-152.
5. Shima K, Kuhlenbäumer G, Rupp J (2010) Chlamydia pneumoniae infection and Alzheimer's disease: A connection to remember? Med Microbiol Immunol 199, 283-289.
6. Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, McDowell I (2002) Risk factors for Alzheimer's disease: A prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156, 445-453. (Pubitemid 34976983)
7. Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J, Hoyte K, Gustafson A, Liu Y, Lu Y, Bhangale T, Graham RR, Huttenlocher J, Bjornsdottir G, Andreassen OA, Jönsson EG, Palotie A, BehrensTW,MagnussonOT,Kong A, Thorsteinsdottir U,Watts RJ, StefanssonK(2012)Amutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488, 96-99.
8. Prusiner SB (1989) Scrapie prions. Annu Rev Microbiol 43, 345-374. (Pubitemid 19250051)
9. Prusiner SB (2012) A unifying role for prions in neurodegenerative diseases. Science 336, 1511-1513.
10. Tyas SL, Manfreda J, Strainc LA, Montgomery PR (2001) Risk factors for Alzheimer's disease: A population-based, longitudinal study in Manitoba, Canada. Int J Epidemiol 30, 590-597. (Pubitemid 32600256)
11. Verreault R, Laurin D, Lindsay J, De Serres G (2001) Past exposure to vaccines and subsequent risk of Alzheimer's disease. Canad Med Assoc J 165, 1495-1498. (Pubitemid 34060192)
12. Murphy JE (1996) Corynebacterium Diphtheriae, Chapter 32. I: Medical Microbiology, 4th edition, Baron S, ed. University of Texas Medical Branch at Galveston, Galveston, Texas.
13. Miller RA (1996) The aging immune system: Primer and prospectus. Science 273, 70-74. (Pubitemid 26255423)
14. Castle SC (2000) Clinical relevance of age-related immune dysfunction. Clin Inf Dis 31, 578-585. (Pubitemid 32289594)
15. Hawkley LC, Cacioppo JT (2004) Stress and the aging immune system. Brain Behav Immun 18, 114-119. (Pubitemid 38169155)
16. Zhu J, Jiang Y, Xu G, Liu X (2012) Intranasal administration: A potential solution for cross-BBB delivering neurotrophic factors. Histol Histopathol 27, 537-548.
17. Draghia R, Caillaud C, Manicom R, Pavirani A, Kahn A, Poenaru L (1995) Gene delivery into the central nervous system by nasal instillation in rats. Gene Ther 2, 418-423.
18. Frenkel D, Solomon B (2002) Filamentous phage as vectormediated antibody delivery to the brain. Proc Natl Acad Sci U S A 99, 5675-5679. (Pubitemid 34411609)
19. Frenkel D, Dewachter I, Van Leuven F, Solomon B (2003) Reduction of β-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization. Vaccine 21, 1060-1065. (Pubitemid 36139935)
20. Carrera MRA, Kaufmann GF, Mee JM, Meijler MM, Koob GF, JandaKD(2004) Treating cocaine addiction with viruses. Proc Natl Acad Sci U S A 101, 10416-10421. (Pubitemid 38924940)
21. Dickerson TJ, Kaufmann GF, Janda KD (2005) Bacteriophage- mediated protein delivery into the central nervous system and its application in immunopharmacotherapy. Expert Opin Biol Ther 5, 773-781. (Pubitemid 40873886)
22. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment. Arch Neurol 69, 29-38.
23. Bergmann O, Liebl J, Bernard S, Alkass K, Yeung MS, Steier P,KutscheraW, Johnson L, Landén M, Druid H, Spalding KL, Frisén J (2012) The age of olfactory bulb neurons in humans. Neuron 74, 634-639.
24. Serby M, Larson P, Kalstein DT (1991) The nature, course of olfactory deficits in Alzheimer's disease. Am J Psychiatry 148, 357-360.
25. Murphy C, Gilmore MM, Seery CS, Salmon DP, Lasker BR (1990) Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol Aging 11, 465-469. (Pubitemid 20274579)
26. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
27. Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, Duff K (2012) Trans-synaptic spread of tau pathology in vivo. PLoS one 7, e31302.
28. de Calignon A, Polydoro M, Suárez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, Pitstick R, Sahara N, Ashe KH, Carlson GA, Spires-Jones TL, Hyman BT (2012) Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73, 685-697.
29. Langstrom NS, Anderson JP, Lindroos HG,Winblad B,Wallace WC (1989) Alzheimer's disease-associated reduction of polysomal mRNA translation. Mol Brain Res 5, 259-269. (Pubitemid 19128098)
30. Johnson G, Gotlib J, HaroutunianV, Bierer L, Nairn A, Merril C,WallaceW(1992) Increased phosphorylation of elongation factor 2 in Alzheimer's disease. Mol Brain Res 15, 319-326.
31. Álvarez G, Aldudo J, Alonso M, Santana S, Valdivieso F (2012) Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells. J Neurosci Res 90, 1020-1029.
32. Honjoa K, van Reekumb R, Nicolaas PLG, Verhoeff N (2009) Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement 5, 348-360.
33. Moreno JA, Radford H, Peretti D, Steinert JR, Verity N, Martin MG, Halliday M, Morgan J, Dinsdale D, Ortori CA, Barrett DA, Tsaytler P, Bertolotti A,Willis AE, Bushell M, Mallucci GM (2012) Sustained translational repression by eIF2a-P mediates prion neurodegeneration. Nature 485, 507-512.
34. Pollack A (2012) Small trial hints drug can slow Alzheimer's. The New York Times, July 17, 2012, http://www.nytimes.com/2012/07/18/business/study- showsdrug-may-help-alzheimers-patients.html
35. FDA Approval. (2011) Expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, http://www.fda.gov/ downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm262892.pdf